Cost- effectiveness Analysis of Type 2 Diabetes Screening: A case study in Shiraz, Iran

Economic evaluation includes evaluation of costs and benefits of screening. One of the economic evaluation methods is cost-effectiveness analysis. The aim of this study was cost-effectiveness analysis of type 2 diabetes screening in Shiraz، Iran. The target population of this cross-sectional study consisted of all Shiraz population over 30 years old. A total of 171067 persons old who had been referred for diabetes screening to 69 government health centers، 30 health stations of Shiraz and 10 clinics affiliated to Shiraz University of Medical Sciences were included. In this study، costs included screening، surveillance and effectiveness costs of averted disability-adjusted life years due to diabetes (DALYs). The lost disability-adjusted life years due to diabetes، in the absence of screening diabetic patients was equal to 871. 9327 years in research popoulation. This rate was equal to 10. 3886 for diabetic retinopathy، 29. 5624 for diabetic neuropathy، 0. 0343 for diabetic foot and 83. 8728 for diabetic nephropathy. The obtained ICER was 49111444 Rials per each DALY averted. The plan saved 871. 9327 years of the individual lives covered by the program and according to the World Health Organization threshold this screening is costeffective.